Charles M. Baum
2015
In 2015, Charles M. Baum earned a total compensation of $2.2M as President and Chief Executive Officer at Mirati Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,500 |
|---|---|
| Option Awards | $1,489,200 |
| Salary | $530,272 |
| Other | $2,814 |
| Total | $2,247,786 |
Baum received $1.5M in option awards, accounting for 66% of the total pay in 2015.
Baum also received $225.5K in non-equity incentive plan, $530.3K in salary and $2.8K in other compensation.
Rankings
In 2015, Charles M. Baum's compensation ranked 4,275th out of 13,638 executives tracked by ExecPay. In other words, Baum earned more than 68.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,275 out of 13,638 | 69th |
Division Manufacturing | 1,565 out of 5,190 | 70th |
Major group Chemicals And Allied Products | 568 out of 1,854 | 69th |
Industry group Drugs | 450 out of 1,528 | 71st |
Industry Pharmaceutical Preparations | 355 out of 1,182 | 70th |
Source: SEC filing on April 20, 2017.
Baum's colleagues
We found three more compensation records of executives who worked with Charles M. Baum at Mirati Therapeutics in 2015.